AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25737517 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate and calcium (bisphosphonate group, n = 14)
Number of subjects: 26
Study 25737517 — intervention group
Group type: COMPARATOR
Intervention: Calcium only (control group, n = 12)
Number of subjects: 26
Study 24372760 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill stress echocardiography (SE)
Number of subjects: 400
Study 24372760 — intervention group
Group type: COMPARATOR
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 400
Study 22569132 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative FIO2 more than 0.9
Number of subjects: 100
Study 22569132 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative FIO2 0.3
Number of subjects: 100
Study 22569132 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (3-5 cm H2O)
Number of subjects: 100
Study 22569132 — intervention group
Group type: COMPARATOR
Intervention: No positive end-expiratory pressure
Number of subjects: 100
Study 19713253 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive paravertebral injections with a mixture of 10 mL 0.25% bupivacaine and 40 mg methylprednisolone acetate every 48 h for a week
Number of subjects: 132
Study 19713253 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (oral antivirals and analgesics)
Number of subjects: 132
Study 19713253 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive paravertebral injections with local anesthetics and steroids
Number of subjects: 132
Study 19713253 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (paravertebral and standard therapy)
Number of subjects: 132
Study 17124578 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine 150 mg daily for 6 days
Number of subjects: 12
Study 15225946 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Number of subjects: 119
Study 15225946 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg
Number of subjects: 119
Study 15225946 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g with codeine 60 mg
Number of subjects: 119
Study 15225946 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Vitamin C 50 mg)
Number of subjects: 119
Study 11172189 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation
Number of subjects: 52
Study 11172189 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with supplemental oxygen and no ventilatory support
Number of subjects: 52
Study 9703405 — intervention group
Group type: EXPERIMENTAL
Intervention: First metacarpal osteotomy
Number of subjects: 17
Study 9703405 — intervention group
Group type: COMPARATOR
Intervention: Abductor pollicis longus tendon arthroplasty
Number of subjects: 17
Study 8014493 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 215
Study 8014493 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetrexate plus leucovorin
Number of subjects: 215
Study 2605073 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 2605073 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 0
Study 2605073 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane and Isoflurane
Number of subjects: 0
Study 31558252 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-centered teaching intervention and automatic reminders
Number of subjects: 525
Study 31558252 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 525
Study 31558252 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall participants
Number of subjects: 525
Study 29060358 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity monitoring using accelerometers over one week, fractal dimension D0 of activity series
Number of subjects: 813
Study 29060358 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity monitoring using accelerometers over one week, Hurst exponents
Number of subjects: 813
Study 29060358 — intervention group
Group type: COMPARATOR
Intervention: Activity monitoring using accelerometers over one week, approximate entropy
Number of subjects: 813
Study 26231554 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback pelvic floor muscle exercise plus support group
Number of subjects: 244
Study 26231554 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback pelvic floor muscle exercise plus telephone contact
Number of subjects: 244
Study 26231554 — intervention group
Group type: COMPARATOR
Intervention: Usual care without intervention
Number of subjects: 244
Study 23675759 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability awareness training program
Number of subjects: 156
Study 23675759 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 156
Study 21233425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive early education program
Number of subjects: 111
Study 21233425 — intervention group
Group type: COMPARATOR
Intervention: Nutritional supplements and parental counseling
Number of subjects: 111
Study 20420791 — intervention group
Group type: EXPERIMENTAL
Intervention: Toprel 100 mg
Number of subjects: 20
Study 20420791 — intervention group
Group type: COMPARATOR
Intervention: Topamax 100 mg
Number of subjects: 20
Study 17084803 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein (10 or 20 mg/day)
Number of subjects: 0
Study 17084803 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein + Zeaxanthin (10 or 20 mg/day)
Number of subjects: 0
Study 17084803 — intervention group
Group type: EXPERIMENTAL
Intervention: Zeaxanthin (10 or 20 mg/day)
Number of subjects: 0
Study 17084803 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 16281998 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Disease Self‐Management Programme (CDSMP)
Number of subjects: 476
Study 16281998 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 476
Study 12141769 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic packing (cotton gauze strips with polymyxin‐B‐sulfate and oxytetracycline ointment)
Number of subjects: 110
Study 12141769 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic-free packing (polyvinyl acetate sponge and cotton gauze strips with sea‐salt ointment)
Number of subjects: 110
Study 10199248 — intervention group
Group type: EXPERIMENTAL
Intervention: Active epidural analgesic paste
Number of subjects: 60
Study 10199248 — intervention group
Group type: COMPARATOR
Intervention: Placebo paste
Number of subjects: 60
Study 7755526 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppression group (instructed 'not to think of a spider')
Number of subjects: 48
Study 7755526 — intervention group
Group type: COMPARATOR
Intervention: Control group (instructed 'think about anything')
Number of subjects: 48
Study 7755526 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (third period instructed 'think about anything')
Number of subjects: 48
Study 2304838 — intervention group
Group type: COMPARATOR
Intervention: Project nurse intervention involving daily hospital visits, coordination of discharge planning, and home visits post-discharge.
Number of subjects: 0
Study 6992902 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (6 mg/day)
Number of subjects: 20
Study 6992902 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine (150 mg/day)
Number of subjects: 20
Study 31187424 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 µg/kg IV followed by 0.5 µg/kg/h infusion during surgery)
Number of subjects: 89
Study 31187424 — intervention group
Group type: COMPARATOR
Intervention: Saline (same doses as DEX)
Number of subjects: 89
Study 28484280 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Advice
Number of subjects: 0
Study 28484280 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 0
Study 25792695 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 138
Study 25792695 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 138
Study 22829349 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous self-directed pushing
Number of subjects: 249
Study 22829349 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal perineal massage
Number of subjects: 249
Study 22829349 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of spontaneous pushing plus perineal massage
Number of subjects: 249
Study 22829349 — intervention group
Group type: COMPARATOR
Intervention: Coached or directed pushing (routine care)
Number of subjects: 249
Study 21894697 — intervention group
Group type: EXPERIMENTAL
Intervention: Najia fa
Number of subjects: 30
Study 21894697 — intervention group
Group type: EXPERIMENTAL
Intervention: Nazi fa
Number of subjects: 30
Study 21894697 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangzi Shike Zhuxue fa
Number of subjects: 30
Study 21894697 — intervention group
Group type: COMPARATOR
Intervention: Najia fa vs Nazi fa
Number of subjects: 30
Study 21894697 — intervention group
Group type: COMPARATOR
Intervention: Najia fa vs Yangzi Shike Zhuxue fa
Number of subjects: 30
Study 21894697 — intervention group
Group type: COMPARATOR
Intervention: Najia fa vs Nazi fa in Wushi
Number of subjects: 30
Study 21894697 — intervention group
Group type: COMPARATOR
Intervention: Najia fa vs Yangzi Shike Zhuxue fa in Wushi
Number of subjects: 30
Study 19948625 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (5, 10, or 15 mg/day)
Number of subjects: 98
Study 19948625 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 98
Study 19948625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 17925431 — intervention group
Group type: EXPERIMENTAL
Intervention: Management at reference centers (RCs) using full polysomnography
Number of subjects: 88
Study 17925431 — intervention group
Group type: COMPARATOR
Intervention: Management at non-reference centers (NRCs) using respiratory polygraphy
Number of subjects: 88
Study 15152826 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix proteins (EMD)
Number of subjects: 70
Study 15152826 — intervention group
Group type: COMPARATOR
Intervention: Subpedicle connective tissue graft (CTG)
Number of subjects: 70
Study 11772231 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy administered for six months after surgery for Dukes C colon cancer
Number of subjects: 400000
Study 11772231 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional chemotherapy for advanced CRC
Number of subjects: 400000
Study 11772231 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer therapeutic concepts based on molecular understanding
Number of subjects: 400000
Study 9059228 — intervention group
Group type: EXPERIMENTAL
Intervention: Potato fibre (PF)
Number of subjects: 0
Study 9059228 — intervention group
Group type: EXPERIMENTAL
Intervention: Maize fibre (MF)
Number of subjects: 0
Study 9059228 — intervention group
Group type: EXPERIMENTAL
Intervention: Both fibres (PF and MF)
Number of subjects: 0
Study 9059228 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (control)
Number of subjects: 0
Study 7951554 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 120
Study 7951554 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with acromegaly
Number of subjects: 120
Study 7951554 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with GH deficiency
Number of subjects: 120
Study 7951554 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma IGF-I levels
Number of subjects: 120
Study 3148145 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam on nights N3, N4, N5
Number of subjects: 24
Study 3148145 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam on nights N3, N4, N5
Number of subjects: 24
Study 3148145 — intervention group
Group type: COMPARATOR
Intervention: Placebo every night (control group)
Number of subjects: 24
Study 3148145 — intervention group
Group type: COMPARATOR
Intervention: Placebo on nights N0, N3, N5 (for groups B and C)
Number of subjects: 24
Study 3148145 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal night (N6)
Number of subjects: 24
Study 30051753 — intervention group
Group type: EXPERIMENTAL
Intervention: EPI-743
Number of subjects: 0
Study 30051753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25749614 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon catheter dilation technology combined with a fibrolaryngoscope
Number of subjects: 30
Study 25749614 — intervention group
Group type: COMPARATOR
Intervention: Conventional nasal endoscopic sinus surgery
Number of subjects: 30
Study 25516423 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation and standard case management
Number of subjects: 0
Study 25516423 — intervention group
Group type: COMPARATOR
Intervention: Standard case management alone
Number of subjects: 0
Study 22668619 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitestrip
Number of subjects: 49
Study 22668619 — intervention group
Group type: COMPARATOR
Intervention: Polysomnography
Number of subjects: 49
Study 21092614 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical acupuncture stimulation therapy combined with pelvic floor muscle therapy (PFMT)
Number of subjects: 109
Study 21092614 — intervention group
Group type: COMPARATOR
Intervention: PFMT (control group)
Number of subjects: 109
Study 18176736 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training (80% of maximum) twice weekly for 10 weeks
Number of subjects: 24
Study 18176736 — intervention group
Group type: COMPARATOR
Intervention: Usual daily activities (Control group)
Number of subjects: 24
Study 18176736 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 24
Study 15014903 — intervention group
Group type: EXPERIMENTAL
Intervention: 11C‐choline PET
Number of subjects: 126
Study 15014903 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG PET
Number of subjects: 126
Study 12162755 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim (granulocyte colony‐stimulating factor, G‐CSF)
Number of subjects: 82
Study 9651731 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate (HR) < 60 beats.min-1
Number of subjects: 8915
Study 9651731 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate (HR) > 100 beats.min-1
Number of subjects: 8915
Study 8694984 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunstar Do New Type toothbrush
Number of subjects: 33
Study 8694984 — intervention group
Group type: COMPARATOR
Intervention: Reach Compact Head toothbrush
Number of subjects: 33
Study 8694984 — intervention group
Group type: COMPARATOR
Intervention: New Dental‐H toothbrush
Number of subjects: 33
Study 2540141 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestin (20 mg tid medroxyprogesterone acetate)
Number of subjects: 12
Study 2540141 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen (1.25 mg bid conjugated equine estrogens)
Number of subjects: 12
Study 2540141 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined progestin and estrogen
Number of subjects: 12
Study 2540141 — intervention group
Group type: COMPARATOR
Intervention: Mild exercise
Number of subjects: 12
Study 2540141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 628065 — intervention group
Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid
Number of subjects: 0
Study 628065 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholic acid
Number of subjects: 0
Study 628065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31277790 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl 4 g/day
Number of subjects: 246
Study 31277790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study 30695422 — intervention group
Group type: EXPERIMENTAL
Intervention: Muxiang Shunqi Pill (MSP), 6 g each time, three times per day, taken 30 min after dinner for 4 weeks
Number of subjects: 40
Study 30695422 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosapride Tablet (MT), 5 mg each time, three times per day, taken 30 min before dinner for 4 weeks
Number of subjects: 40
Study 30695422 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 subjects with normal physical examinations)
Number of subjects: 40
Study 26092202 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 60
Study 26092202 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 60
Study 23083839 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg (additional dose)
Number of subjects: 20
Study 23083839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21806771 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telemonitoring of blood pressure and bilingual nurse counseling
Number of subjects: 359
Study 19495545 — intervention group
Group type: EXPERIMENTAL
Intervention: fesoterodine 4 mg
Number of subjects: 1548
Study 19495545 — intervention group
Group type: EXPERIMENTAL
Intervention: fesoterodine 8 mg
Number of subjects: 1548
Study 19495545 — intervention group
Group type: EXPERIMENTAL
Intervention: tolterodine ER 4 mg
Number of subjects: 1548
Study 19495545 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1548
Study 16678593 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (n = 25)
Number of subjects: 49
Study 16678593 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 24)
Number of subjects: 49
Study 15261707 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine or venlafaxine
Number of subjects: 51
Study 15261707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 11292002 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (4 microg/kg b.i.d.) + naltrexone (25 mg b.i.d.)
Number of subjects: 20
Study 11292002 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 9022118 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% dorzolamide (three times daily)
Number of subjects: 184
Study 9022118 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol (twice daily)
Number of subjects: 184
Study 9022118 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% dorzolamide (twice daily) added to 0.5% timolol
Number of subjects: 184
Study 7939393 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide (1200 mg orally)
Number of subjects: 20
Study 7939393 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard meal with 15% soybean oil
Number of subjects: 20
Study 7939393 — intervention group
Group type: COMPARATOR
Intervention: Standard meal without fat
Number of subjects: 20
Study 7939393 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide
Number of subjects: 20
Study 7939393 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard meal with fat
Number of subjects: 20
Study 7939393 — intervention group
Group type: COMPARATOR
Intervention: Standard meal in DU patients
Number of subjects: 20
Study 2887519 — intervention group
Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 7
Study 2887519 — intervention group
Group type: EXPERIMENTAL
Intervention: prazosin
Number of subjects: 7
Study 2887519 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 7
Study 2887519 — intervention group
Group type: EXPERIMENTAL
Intervention: propranolol
Number of subjects: 7
Study 30646253 — intervention group
Group type: EXPERIMENTAL
Intervention: ASSIP intervention (3 manual-based therapy sessions followed by regular personalized letters over 24 months)
Number of subjects: 120
Study 30646253 — intervention group
Group type: COMPARATOR
Intervention: Control group (single suicide risk assessment)
Number of subjects: 120
Study 30646253 — intervention group
Group type: EXPERIMENTAL
Intervention: ASSIP intervention
Number of subjects: 120
Study 26480931 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (DXM) 40 mg/d for 4 days
Number of subjects: 192
Study 26480931 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (PDN) 1.0 mg/kg daily for 4 weeks
Number of subjects: 192
Study 24670122 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 200 mg daily for 12 weeks
Number of subjects: 46
Study 24670122 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 400 mg daily for 12 weeks
Number of subjects: 46
Study 24670122 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 600 mg daily for 12 weeks
Number of subjects: 46
Study 24670122 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 800 mg daily for 12 weeks
Number of subjects: 46
Study 24147154 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational posters displayed for 2 weeks in intervention schools
Number of subjects: 515
Study 24147154 — intervention group
Group type: COMPARATOR
Intervention: No posters displayed in control schools
Number of subjects: 515
Study 22586319 — intervention group
Group type: EXPERIMENTAL
Intervention: erlotinib
Number of subjects: 255
Study 22586319 — intervention group
Group type: EXPERIMENTAL
Intervention: vandetanib
Number of subjects: 255
Study 22586319 — intervention group
Group type: EXPERIMENTAL
Intervention: erlotinib plus bexarotene
Number of subjects: 255
Study 22586319 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 255
Study 22586319 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 255
Study 18622420 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy and peripheral stem-cell reinfusion
Number of subjects: 392
Study 18622420 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of neutropenia >10 days
Number of subjects: 392
Study 18622420 — intervention group
Group type: EXPERIMENTAL
Intervention: Using the catheter for both stem-cell apheresis and high-dose chemotherapy
Number of subjects: 392
Study 18622420 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of total parenteral nutrition (TPN)
Number of subjects: 392
Study 17076227 — intervention group
Group type: EXPERIMENTAL
Intervention: B+Q (Bisoprolol + Quinapril)
Number of subjects: 63
Study 17076227 — intervention group
Group type: EXPERIMENTAL
Intervention: B+V (Bisoprolol + Valsartan)
Number of subjects: 63
Study 17076227 — intervention group
Group type: EXPERIMENTAL
Intervention: B+Q+V (Bisoprolol + Quinapril + Valsartan)
Number of subjects: 63